Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis

Fig. 4

MEF2C-AS1 hypermethylation among patients at all stages during colorectal carcinogenesis in in-house step 3. a NAA patients. b AA patients. c CRC patients. Line chart presents the methylation level of each individual CpG site. The distribution of the mean methylation level of all individual CpG sites is shown in the scatter plot. Pie chart presents the percentage of patients with hypermethylation or hypomethylation status. AA, advanced adenoma; CRC, colorectal cancer; NAA, non-advanced adenoma. ***p < 0.001

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us